Racial disparities in the immunotherapeutic outcomes of patients with non-small cell lung cancer (NSCLC): An in-depth systematic review and meta-analysis. Introduction of FDA approved ICI and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results